Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market
Holding PHAT?
Track your performance easily

Phathom Pharmaceuticals (PHAT) Technical Analysis

249 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
5Neutral
3Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Phathom Pharmaceuticals’s (PHAT) Moving Averages Convergence Divergence (MACD) indicator is 0.27, suggesting Phathom Pharmaceuticals is a Sell.
Phathom Pharmaceuticals’s (PHAT) 20-Day exponential moving average is 11.34, while Phathom Pharmaceuticals’s (PHAT) share price is $11.74, making it a Buy.
Phathom Pharmaceuticals’s (PHAT) 50-Day exponential moving average is 10.89, while Phathom Pharmaceuticals’s (PHAT) share price is $11.74, making it a Buy.

Phathom Pharmaceuticals (PHAT) Pivot Points

Aug 24, 2024, 04:27 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
10.30
10.71
10.99
11.40
11.68
12.09
12.37
Fibonacci
10.71
10.97
11.13
11.40
11.66
11.82
12.09
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Phathom Pharmaceuticals (PHAT) Moving Averages

Aug 24, 2024, 04:27 AM
Period
Simple
Exponential
MA5
11.70Buy
11.60Buy
MA10
11.76Sell
11.54Buy
MA20
11.19Buy
11.34Buy
MA50
10.85Buy
10.89Buy
MA100
10.30Buy
10.47Buy
MA200
9.31Buy
10.29Buy
Phathom Pharmaceuticals’s (PHAT) 10-Day exponential moving average is 11.54, while Phathom Pharmaceuticals’s (PHAT) share price is $11.74, making it a Buy.
Phathom Pharmaceuticals’s (PHAT) 100-Day exponential moving average is 10.47, while Phathom Pharmaceuticals’s (PHAT) share price is $11.74, making it a Buy.
Phathom Pharmaceuticals’s (PHAT) stock price is $11.74 and Phathom Pharmaceuticals’s (PHAT) 50-day simple moving average is 10.85, creating a Buy signal.
Phathom Pharmaceuticals’s (PHAT) stock price is $11.74 and Phathom Pharmaceuticals’s (PHAT) 100-day simple moving average is 10.30, creating a Buy signal.
Phathom Pharmaceuticals’s (PHAT) stock price is $11.74 and Phathom Pharmaceuticals’s (PHAT) 200-day simple moving average is 9.31, creating a Buy signal.

Phathom Pharmaceuticals (PHAT) Technical Indicators

Aug 24, 2024, 04:27 AM
Name
Value
Implied Action
RSI (14)
54.98
Neutral
STOCH (9,6)
32.90
Neutral
STOCHRSI (14)
47.07
Neutral
MACD (12,26)
0.27
Sell
ADX (14)
18.60
Buy
Williams %R
-44.78
Buy
CCI (14)
38.08
Neutral
ATR (14)
0.84
-
Ultimate Oscillator
45.11
Neutral
ROC
12.56
Buy
Phathom Pharmaceuticals’s (PHAT) Relative Strength Index (RSI) is 54.98, creating a Neutral signal.
Phathom Pharmaceuticals’s (PHAT) Trend Strength Indicator (ADX) is 18.60, creating a Buy signal.
Phathom Pharmaceuticals’s (PHAT) Commodity Channel Index (CCI) is 38.08, creating a Neutral signal.
Phathom Pharmaceuticals’s (PHAT) Price Rate of Change (ROC) is 12.56, creating a Buy signal.

FAQ

Is PHAT a Buy, Hold, or Sell?
Based on PHAT’s technical indicators, PHAT is a Buy.
    What is PHAT’s RSI (14)?
    PHAT’s RSI (14) is 54.98, which suggests PHAT is a Neutral.
      What is PHAT’s MACD?
      PHAT’s MACD is 0.27, which suggests PHAT is a Sell.
        What is PHAT’s 5-day moving average?
        PHAT’s 5-day moving average is 11.70, which suggests PHAT is a Buy.
          What is PHAT’s 20-day moving average?
          PHAT 20-day moving average is 11.19, which suggests PHAT is a Buy.
            What is PHAT’s 50-day moving average?
            PHAT’s 50-day moving average is 10.85, which suggests PHAT is a Buy.
              What is PHAT’s 200-day moving average?
              PHAT’s 200-day moving average is 9.31, which suggests PHAT is a Buy.
                What is PHAT’s Williams % R (14)?
                PHAT’s Williams % R (14) is -44.78, which suggests PHAT is a Buy.
                  What is PHAT’s CCI (14)?
                  PHAT’s CCI (14) is 38.08, which suggests PHAT is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis